<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Gastrointestinal tract small cell <z:mp ids='MP_0002038'>carcinoma</z:mp> is an infrequent and aggressive <z:hpo ids='HP_0002664'>neoplasm</z:hpo> that represents 0.1-1% of gastrointestinal <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Very few cases of small cell <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> arising in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> have been reported in the literature </plain></SENT>
<SENT sid="2" pm="."><plain>An extremely rare case of primary small cell <z:mp ids='MP_0002038'>carcinoma</z:mp> of the distal third of the esophagus arising from dysplastic <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is herein presented </plain></SENT>
<SENT sid="3" pm="."><plain>CASE PRESENTATION: A 62-year-old man with <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> history presented with epigastric pain, epigastric fullness, <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, <z:hpo ids='HP_0002039'>anorexia</z:hpo>, and <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Esophagogastroscopy revealed an ulceroproliferative, intraluminar mass in the distal esophagus obstructing the esophageal lumen </plain></SENT>
<SENT sid="5" pm="."><plain>Biopsy showed small cell <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Contrast-enhanced chest and abdominal computed tomography demonstrated a large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> of the distal third of the esophagus without any <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> or distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Preoperative chemotherapy with <z:chebi fb="0" ids="27899">cisplatine</z:chebi> and <z:chebi fb="0" ids="4911">etoposide</z:chebi> for 3 months resulted in a significant reduction of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>After en block esophagectomy with two field lymph node dissection, proximal gastrectomy, and cervical esophagogastric anastomosis, the patient was discharged on the 14th postoperative day </plain></SENT>
<SENT sid="9" pm="."><plain>Histopathology revealed a primary small cell <z:mp ids='MP_0002038'>carcinoma</z:mp> of the distal third of the esophagus arising from dysplastic <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The patient received another 3 month course of postoperative chemotherapy with the same agents and remained free of disease at 12 month review </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Although small cell <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> is rare and its association with dysplastic <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is extremely infrequent, the high carcinogenic risk of Barrett's epithelium should be kept in mind </plain></SENT>
<SENT sid="12" pm="."><plain>Prognosis is quite unfavorable; a better prognosis might be possible with early diagnosis and treatment strategies incorporating chemotherapy along with oncological radical surgery and/or radiotherapy as part of a multimodality approach </plain></SENT>
<SENT sid="13" pm="."><plain>Since treatment protocols are not well established due to the rarity of the <z:hpo ids='HP_0002664'>neoplasm</z:hpo>, multi-institutional studies are needed to obtain sufficiently large populations for investigation and optimization of therapy of the disease </plain></SENT>
</text></document>